Cerebrospinal Fluid Amyloid 1-42 Levels in the Mild Cognitive Impairment Stage of Alzheimer's Disease

Author： Maruyama M. Arai H. Sugita M. Tanji H. Higuchi M. Okamura N. Matsui T. Higuchi S. Matsushita S. Yoshida H. Sasaki H.

Publisher： Elsevier

ISSN： 0014-4886

Source： Experimental Neurology, Vol.172, Iss.2, 2001-12, pp. : 433-436

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cerebrospinal fluid TAU protein and amyloid β42 in mild cognitive impairment: prediction of progression to Alzheimer's disease and correlation with the neuropsychological examination

By Ivanoiu Adrian Jm Sindic Christian

Neurocase, Vol. 11, Iss. 1, 2005-02 ,pp. : 32-39

Routledge Ltd

Access to resources Recommend Favorite

Biomarkers of Alzheimer′s Disease in the Cerebrospinal Fluid of Spanish Patients With Mild Cognitive Impairment

By Monge-Argilés J. Muñoz-Ruiz C. Pampliega-Pérez A. Gómez-López M. Sánchez-Payá J. Rodríguez Borja E. Ruiz-Vegara M. Montoya-Gutiérrez F. Leiva-Santana C.

Neurochemical Research, Vol. 36, Iss. 6, 2011-06 ,pp. : 986-993

Springer Publishing Company

Access to resources Recommend Favorite

Cerebrospinal fluid levels of phosphorylated tau and Aβ1-38/Aβ1-40/Aβ1-42 in Alzheimer's disease with PS1 mutations

By Ikeda Masaki

Amyloid: The Journal of Protein Folding Disorders, Vol. 20, Iss. 2, 2013-06 ,pp. : 107-112

Informa Healthcare

Access to resources Recommend Favorite

MILD COGNITIVE IMPAIRMENT: AGING TO ALZHEIMER’S DISEASE

By Snowden J. S.

Brain, Vol. 127, Iss. 1, 2004-01 ,pp. : 231-233

Oxford University Press

Access to resources Recommend Favorite

Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage alzheimer’s disease

By Morris John Price Joseph

Journal of Molecular Neuroscience, Vol. 17, Iss. 2, 2001-10 ,pp. : 101-118

Humana Press, Inc

Access to resources Recommend Favorite